● The stock, which is currently worth 2016 to 0.55 times its sales, is clearly overvalued in comparison with peers.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the past year, analysts have significantly revised downwards their profit estimates.
● Below the resistance at 5.49 EUR, the stock shows a negative configuration when looking looking at the weekly chart.